MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Compatible with caution

Zopiclone 7.5mg tablets (Crescent Pharma Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Compatible with caution

Zopiclone 7.5mg tablets (Flamingo Pharma (UK) Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Compatible with caution

Zopiclone 7.5mg tablets (Medihealth (Northern) Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Compatible with caution

Zopiclone 7.5mg tablets (Milpharm Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Compatible with caution

Zopiclone 7.5mg tablets (Novumgen Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Compatible with caution

Zopiclone 7.5mg tablets (Phoenix Healthcare Distribution Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Compatible with caution

Zopiclone 7.5mg tablets (Ria Generics Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Compatible with caution

Zopiclone 7.5mg tablets (Sigma Pharmaceuticals Plc)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Compatible with caution

Zopiclone 7.5mg tablets (Teva UK Ltd)

Explore other Zopiclone formulations Explore other Zopiclone 7.5mg tablets suppliers

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Incompatible

Zoton FasTab 15mg (Pfizer Ltd)

Explore other Lansoprazole formulations Explore other Lansoprazole 15mg orodispersible tablets suppliers

Stability Notes

Highly sensitive to moisture, so unsuitable for inclusion in MCA.

Provenance

This compatibility recommendation is derived from Zoton FasTab 15mg (Pfizer Ltd).

Incompatible

Zoton FasTab 30mg (Pfizer Ltd)

Explore other Lansoprazole formulations Explore other Lansoprazole 30mg orodispersible tablets suppliers

Stability Notes

Highly sensitive to moisture, so unsuitable for inclusion in MCA.

Provenance

This compatibility recommendation is derived from Zoton FasTab 30mg (Pfizer Ltd).

Incompatible

Zovirax 200mg dispersible tablets (GlaxoSmithKline UK Ltd)

Explore other Aciclovir formulations Explore other Aciclovir 200mg dispersible tablets suppliers

Stability Notes

Store in airtight containers. Protect from light and moisture. Disintegrates outside packaging.

Provenance

This compatibility recommendation is derived from Zovirax 200mg dispersible tablets (GlaxoSmithKline UK Ltd).

Incompatible

Zovirax 200mg dispersible tablets (Sigma Pharmaceuticals Plc)

Explore other Aciclovir formulations Explore other Aciclovir 200mg dispersible tablets suppliers

Stability Notes

Store in airtight containers. Protect from light and moisture. Disintegrates outside packaging.

Provenance

This compatibility recommendation is derived from Zovirax 200mg dispersible tablets (GlaxoSmithKline UK Ltd).

Incompatible

Zovirax 800mg dispersible tablets (Sigma Pharmaceuticals Plc)

Explore other Aciclovir formulations Explore other Aciclovir 800mg dispersible tablets suppliers

Stability Notes

Store in airtight containers. Protect from light and moisture. Disintegrates outside packaging.

Provenance

This compatibility recommendation is derived from Zovirax 800mg dispersible tablets (GlaxoSmithKline UK Ltd).

No Stability Information

Zubsolv 1.4mg/0.36mg sublingual tablets (Accord-UK Ltd)

Explore other Buprenorphine + Naloxone formulations Explore other Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free suppliers

Stability Notes

There are no stability notes available for this medicine.
Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Compatible with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.